C. Sourbier and T. Massfelder, Parathyroid hormone-related protein in human renal cell carcinoma, Cancer Letters, vol.240, issue.2, pp.170-182, 2006.
DOI : 10.1016/j.canlet.2005.08.020

P. Clark, Recent advances in targeted therapy for renal cell carcinoma, Current Opinion in Urology, vol.17, issue.5, pp.331-336, 2007.
DOI : 10.1097/MOU.0b013e3282c508e0

R. Motzer and P. Russo, SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA, The Journal of Urology, vol.163, issue.2, pp.408-417, 2000.
DOI : 10.1016/S0022-5347(05)67889-5

R. Motzer, T. Hutson, P. Tomczak, M. Michaelson, R. Bukowski et al., Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.2, pp.115-124, 2007.
DOI : 10.1056/NEJMoa065044

R. Bukowski, Sorafenib in advanced clear-cell renal-cell carcinoma, New Engl J Med, vol.356, pp.125-134, 2007.

C. Friedrich, Von Hippel-Lindau Syndrome, Cancer, vol.10, issue.S11, pp.2478-2485, 1999.
DOI : 10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5

W. Kaelin and . Jr, The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma, Clinical Cancer Research, vol.13, issue.2, pp.680-684, 2007.
DOI : 10.1158/1078-0432.CCR-06-1865

T. Seagroves and R. Johnson, Two HIFs may be better than one, Cancer Cell, vol.1, issue.3, pp.211-213, 2002.
DOI : 10.1016/S1535-6108(02)00048-X

URL : http://doi.org/10.1016/s1535-6108(02)00048-x

C. Sourbier, V. Lindner, H. Lang, A. Agouni, E. Schordan et al., The Phosphoinositide 3-Kinase/Akt Pathway: A New Target in Human Renal Cell Carcinoma Therapy, Cancer Research, vol.66, issue.10, pp.5130-5142, 2006.
DOI : 10.1158/0008-5472.CAN-05-1469

C. Sourbier, S. Danilin, V. Lindner, J. Steger, S. Rothhut et al., Targeting the Nuclear Factor-??B Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy, Cancer Research, vol.67, issue.24, pp.11668-1176, 2007.
DOI : 10.1158/0008-5472.CAN-07-0632

D. Huang, Y. Ding, W. Luo, S. Bender, C. Qian et al., Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo, Cancer Research, vol.68, issue.1, pp.81-88, 2008.
DOI : 10.1158/0008-5472.CAN-07-5311

P. Hueber, D. Iglesias, L. Chu, M. Eccles, and P. Goodyer, In vivo validation of PAX2 as a target for renal cancer therapy, Cancer Letters, vol.265, issue.1, pp.148-155, 2008.
DOI : 10.1016/j.canlet.2008.02.016

J. Sjölund, M. Johansson, S. Manna, C. Norin, A. Pietras et al., Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo, Journal of Clinical Investigation, vol.118, issue.1, pp.217-228, 2008.
DOI : 10.1172/JCI32086DS1

N. Chari and T. Mcdonnell, The Sonic Hedgehog Signaling Network in Development and Neoplasia, Advances in Anatomic Pathology, vol.14, issue.5, pp.344-352, 2007.
DOI : 10.1097/PAP.0b013e3180ca8a1d

I. Louro, E. Bailey, X. Li, L. South, P. Mckie-bell et al., Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation, Cancer Res, vol.62, pp.5867-5873, 2002.

Y. Hedberg, B. Ljungberg, G. Roos, and G. Landberg, Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray, British Journal of Cancer, vol.88, issue.9, pp.1417-1423, 2003.
DOI : 10.1038/sj.bjc.6600922

P. Mazal, M. Stichenwirth, A. Koller, S. Blach, A. Haitel et al., Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study, Modern Pathology, vol.24, issue.4, pp.535-540, 2005.
DOI : 10.1038/modpathol.3800320

M. Varjosalo and J. Taipale, Hedgehog: functions and mechanisms, Genes & Development, vol.22, issue.18, pp.2454-2472, 2008.
DOI : 10.1101/gad.1693608

P. Gill and N. Rosenblum, Control of Murine Kidney Development by Sonic Hedgehog and its GLI Effectors, Cell Cycle, vol.5, issue.13, pp.1426-1430, 2006.
DOI : 10.4161/cc.5.13.2928

N. Dahmane, J. Lee, P. Robins, P. Heller, and A. Ruiz-i-altaba, Activation of the transcription factor Gli1 and the Sonic hedgehog signaling pathway in skin tumours, Nature, vol.389, pp.876-881, 1997.

D. Berman, S. Karhadkar, A. Maitra, R. Montes-de-oca, M. Gerstenblith et al., Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours, Nature, vol.425, issue.6960, pp.846-851, 2003.
DOI : 10.1038/nature01972

E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck et al., Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma, Stem Cells, vol.66, issue.10, pp.2524-2533, 2007.
DOI : 10.1634/stemcells.2007-0166

V. Clement, P. Sanchez, N. De-tribolet, and I. Radovanovic, HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity, Current Biology, vol.17, issue.2, pp.165-172, 2007.
DOI : 10.1016/j.cub.2006.11.033

J. Hwang, Y. Weng, J. Lin, D. Bau, F. Ko et al., Hypoxia-induced compensatory effect as related to Shh and HIF-1?? in ischemia embryo rat heart, Molecular and Cellular Biochemistry, vol.100, issue.1-2, pp.179-187, 2008.
DOI : 10.1007/s11010-008-9708-6

B. Stecca, C. Mas, V. Clement, M. Zbinden, R. Correa et al., Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.5895-5900, 2007.
DOI : 10.1073/pnas.0700776104

G. Maclennan and D. Bostwick, Microvessel density in renal cell carcinoma: Lack of prognostic significance, Urology, vol.46, issue.1, pp.27-30, 1995.
DOI : 10.1016/S0090-4295(99)80153-8

O. Nativ, E. Sabo, A. Reiss, M. Wald, S. Madjar et al., Clinical Significance of Tumor Angiogenesis in Patients with Localized Renal Cell Carcinoma, Urology, vol.51, issue.5, pp.693-696, 1998.
DOI : 10.1016/S0090-4295(98)00019-3

T. Imao, M. Egawa, H. Takashima, K. Koshida, and M. Namiki, Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma, International Journal of Urology, vol.95, issue.11, pp.948-953, 2004.
DOI : 10.1111/j.1442-2042.2004.00931.x

Y. Yao, Y. Pan, J. Chen, X. Sun, Y. Qiu et al., Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF, Ann Clin Lab Sci, vol.37, pp.39-48, 2007.

X. Tang, I. Batty, and C. Downes, Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells, Journal of Biological Chemistry, vol.277, issue.1, pp.338-344, 2002.
DOI : 10.1074/jbc.M108927200

G. Dressler, The Cellular Basis of Kidney Development, Annual Review of Cell and Developmental Biology, vol.22, issue.1, pp.509-529, 2006.
DOI : 10.1146/annurev.cellbio.22.010305.104340

J. Jiang, Regulation of Hh/Gli Signaling by Dual Ubiquitin Pathways, Cell Cycle, vol.5, issue.21, pp.2457-2463, 2006.
DOI : 10.4161/cc.5.21.3406

H. Nakashima, M. Nakamura, H. Yamaguchi, N. Yamanaka, T. Akiyoshi et al., Nuclear Factor-??B Contributes to Hedgehog Signaling Pathway Activation through Sonic Hedgehog Induction in Pancreatic Cancer, Cancer Research, vol.66, issue.14, pp.7041-7049, 2006.
DOI : 10.1158/0008-5472.CAN-05-4588

A. Sagalowsky, The 1997 TNM classification of renal cell carcinoma revisited: the pendulum swings back, Current Opinion in Urology, vol.12, issue.5, pp.371-373, 2002.
DOI : 10.1097/00042307-200209000-00001

T. Massfelder, H. Lang, E. Schordan, V. Lindner, S. Rothhut et al., Parathyroid Hormone-Related Protein Is an Essential Growth Factor for Human Clear Cell Renal Carcinoma and a Target for the von Hippel-Lindau Tumor Suppressor Gene, Cancer Research, vol.64, issue.1, pp.180-188, 2004.
DOI : 10.1158/0008-5472.CAN-03-1968